InfuSystem
INFU
$7.87
Share price
-1.75%
Change (1 day)
-10.77%
Change (1 year)
Categories
Revenue for InfuSystem (INFU)
Revenue in 2023 (TTM): $0.12 B
According to InfuSystem's latest financial reports the company's current revenue (TTM) is $0.12 B. In 2022 the company made a revenue of $0.10 B an increase over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for InfuSystem from 2008 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.12 B | 11.76% |
| 2022 | $0.10 B | 7.36% |
| 2021 | $0.10 B | 5.13% |
| 2020 | $97.38 M | 20.06% |
| 2019 | $81.11 M | 20.82% |
| 2018 | $67.13 M | -5.54% |
| 2017 | $71.07 M | 0.82% |
| 2016 | $70.49 M | -1.18% |
| 2015 | $71.33 M | 7.29% |
| 2014 | $66.48 M | 6.75% |
| 2013 | $62.28 M | 5.87% |
| 2012 | $58.82 M | 7.67% |
| 2011 | $54.63 M | 15.69% |
| 2010 | $47.22 M | 21.21% |
| 2009 | $38.96 M | 10.02% |
| 2008 | $35.41 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Premier PINC | $1.31 B | 946.30% | 🇺🇸 USA |
 DexCom DXCM | $3.62 B | 2,779.76% | 🇺🇸 USA |
 CorVel Corporation
CRVL | $0.77 B | 514.95% | 🇺🇸 USA |
 Biolase
BIOL | $49.16 M | -60.91% | 🇺🇸 USA |